GSK’s Ojjaara Scores Myelofibrosis Nod After Round-The-World Journey

 
• By Alaric DeArment
The FDA approved GSK's Ojjaara for myelofibrosis with anemia • Source: Shutterstock

More from New Products

More from Scrip